Welcome to Aurigene

Aurigene is a clinical stage biotech company committed to bringing novel therapeutics for the treatment of cancer and inflammation.

Based in Bangalore and Kuala Lumpur, Aurigene has fully integrated Drug Discovery & Development infrastructure from Hit Generation to Clinical Development.

Aurigene has pioneered customized models of Drug Discovery & Development collaborations with large-pharmaceutical, mid-pharmaceutical companies and Biotechs.

In over 12 years of working with Pharma, Biotech and Academic partners, in a variety of Therapeutic Areas, Biologies and Chemistries and over 75 integrated Drug Discovery projects, Aurigene has contributed to delivering over 15 small molecule and peptide drug candidates to its biotech and pharmaceutical partners.

Aurigene has out-licensed several first-in-class and best-in-class compounds to pharma and biotech companies for global clinical development, while undertaking clinical POC studies in a few programs in India.

Aurigene has developed deep expertise in cancer and inflammatory disorders, and has continuously invested in its people resources and infrastructure over the years